Skip to main content

Antiemetic Use Among Pregnant Women in the United States: The Escalating Use of Ondansetron

Basic Details
Date
Monday, February 20, 2017
Type
Publication
Description

This report examines ondansetron use in pregnancy in the context of other antiemetic use among a large insured United States population of women delivering live births.

Materials

Pharmacoepidemiology & Drug Safety; DOI:10.1002/pds.4185. [Epub ahead of print]

Related Assessment(s)
Antiemetic Use During Pregnancy
Author(s)

Lockwood G. Taylor PhD, MPH, Steven T. Bird PharmD, PhD, MS, Leyla Sahin MD, Melissa S. Tassinari PhD, Patty Greene PharmD, Marsha E. Reichman PhD, Susan E. Andrade ScD, Katherine Haffenreffer BS, Sengwee Toh ScD

Corresponding Author

L. G. Taylor, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Bldg 22, Rm 2406, Silver Spring, MD 20903, USA. E-mail: lockwood.taylor@fda.hhs.gov